Wayne Kuznar


PSA disadvantages discussed with minority of men

April 01, 2018

A minority of patients are involved in shared decision-making about prostate cancer screening with PSA, but new strategies to incorporate shared decision-making into practice are being investigated.

Multivitamin use may reduce prostate Ca recurrence

March 06, 2018

Long-term use of a multivitamin may protect against recurrence of prostate cancer, particularly in those men who have had radical prostatectomy.

PCa Tx delays development of non-metastatic disease in some patients

March 06, 2018

Enzalutamide (XTANDI) with androgen deprivation therapy delays the development of metastatic disease in men with M0 castration-resistant prostate cancer compared with ADT alone, according to results from the randomized phase III PROSPER study.

RCC immunotherapy combo extends survival

March 01, 2018

An immunotherapy combination of nivolumab (Opdivo) and ipilimumab (Yervoy) extended overall survival compared with sunitinib (SUTENT) as first-line treatment of patients with advanced or metastatic renal cell carcinoma.